Thermo Fisher Scientific Inc.· TMO
🇺🇸 US · LargeSP500NYSE
- Price
- $564.75
- Day
- -1.62%
- Mkt Cap
- $209.87B
- 52W Range
- $435.27 – $643.99
- Volume
- 1.94M
- Beta
- 0.87
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Thermo Fisher Scientific Inc. TMO raised its 2026 outlook after second-quarter earnings and revenues exceeded expectations. The update reflects stronger customer activity, better acquisition performance and improved operating leverage.
Read full article
Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Read full article
Argent Capital Management LLC trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 35.8% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 33,602 shares of the medical research company's stock after selling 18,757 shares during the quarter.
Read full article
TMO is expanding bioproduction, AI tools and clinical data capabilities, but execution will be key as competition intensifies.
Read full article
Amundi raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 22.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,016,260 shares of the medical research company's stock after buying an additional 369,238 shares during the period. Amundi owned
Read full article
Jefferies just named five U.S. dividend stocks to its exclusive Global Best Ideas list, and with the S&P 500 stretched to historically expensive valuations, the case for these high-conviction picks has never been more urgent.
Read full article
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 26-30, 2026, in Anaheim, Calif. Spanning specialty diagnostics, quality management and the full diagnostic continuum, Thermo Fisher's presence at ADLM 2026 reflects its ongoing commitment to addressing unmet clinic.
Read full article
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the global launch of Thermo Scientific™ InstaFlux™, an integrated media-on-demand enrichment workflow that helps food microbiology laboratories simplify media preparation, improve productivity and enhance sample traceability. Food testing laboratories face growing pressure to process more samples, meet turnaround expectations and maintain consistent quality while managing staffing constraints, sustainability goals and inc.
Read full article
Thermo Fisher Scientific NYSE: TMO reported stronger-than-expected second-quarter 2026 results and raised its full-year outlook, citing improving customer activity across end markets, broad-based growth and contributions from recent acquisitions.
Read full article
Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activity lift results, sending shares higher in pre-market trading.
Read full article
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $6.03 per share, beating the Zacks Consensus Estimate of $5.71 per share. This compares to earnings of $5.36 per share a year ago.
Read full article